IVRO (IVRO) Stock Price & Analysis
IVRO (IVRO) fell 24.94% to USD 0.06 as of July 25, 2026 at 22:48 UTC, according to Nexqual real-time market data.
IVRO last closed at USD 0.08; the session ranged USD 0.06–0.06 on volume of 130 shares. Market capitalization is $1.36M, with a 52-week range of USD 0.03–0.16 (OQB). Source: Nexqual, July 25, 2026 at 22:48 UTC.
Key Statistics (as of July 25, 2026 at 22:48 UTC)
| Price | USD 0.06 |
|---|---|
| Change | ▼ 24.94% (down) |
| Previous Close | USD 0.08 |
| Open | USD 0.06 |
| Day Range | USD 0.06 – 0.06 |
| 52-Week Range | USD 0.03 – 0.16 |
| Volume | 130 shares |
| Market Cap | $1.36M |
| Exchange | OQB |
Technical Analysis (IVRO)
Nexqual's technical model rates IVRO "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 22:48 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 10.18 (oversold) |
| vs SMA50 | Below (USD 0.08) |
| MACD | -0 (negative) |
Analyst Ratings (IVRO)
Wall Street analysts rate IVRO "None", per Nexqual as of July 25, 2026 at 22:48 UTC.
| Consensus Rating | None |
|---|
Earnings (IVRO)
Source: Nexqual, July 25, 2026 at 22:48 UTC.
Financials & Fundamentals (IVRO)
| Total Revenue | $811,290 |
|---|---|
| Revenue Growth (YoY) | -12.90% |
| Gross Margin | +80.55% |
| Operating Margin | +6.04% |
| Profit Margin | +13.15% |
| ROE | +7.06% |
| Current Ratio | 16.69 |
| Total Cash | $332,665 |
| Total Debt | $0 |
| Free Cash Flow | $57,666 |
Source: Nexqual, July 25, 2026 at 22:48 UTC.
Financial Health Score (IVRO)
Nexqual rates IVRO's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 22:48 UTC.
| Growth | Critical — Revenue -13% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $333K cash, no debt |
| Cash Flow | Solid — FCF $58K, 7% margin |
| Efficiency | Mixed — ROE 7%, ROA 2.5% |
Ownership (IVRO)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 22.26M |
| Float | 15.52M |
Source: Nexqual, July 25, 2026 at 22:48 UTC.
Leadership (IVRO)
IVRO is led by W. Richard Ulmer (age 82), CEO, President & Chairman, per Nexqual as of July 25, 2026 at 22:48 UTC.
| CEO, President & Chairman | W. Richard Ulmer (age 82) |
|---|---|
| CFO & Director | Cathy L. Richmond |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PCYN | Procyon Corp. | USD 0.26 | ▲ 0% |
| ECIA | Encision, Inc. | USD 0.05 | ▲ 0% |
| SPRS | Surge Components, Inc. | USD 3.84 | ▲ 0.26% |
| PGNT | Paragon Technologies, Inc. | USD 4.78 | ▲ 0% |
| KLYG | Kelyniam Global, Inc. | USD 0.15 | ▲ 7.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 22:48 UTC. This page is informational and not investment advice.